Comparison of the effects of drugs on hyperexcitability induced in hippocampal slices by withdrawal from chronic ethanol consumption

British Journal of Pharmacology

Volumn 123, Issue 2, 1998, Pages 215-222

  Bailey, C P ^a   Molleman, A ^b   Little, H J ^a  

^a DURHAM UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Calcium channel antagonists; Ethanol; Field potentials; Hippocampus; Withdrawal

Indexed keywords

4 [[2 [2 [[(2 ADAMANTYLOXY)CARBONYL]AMINO] 3 (1H INDOL 3 YL) 2 METHYLPROPIONAMIDO] 1 PHENYLETHYL]AMINO] 4 OXOBUTYRIC ACID MEGLUMINE; ALCOHOL; ANTICONVULSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; FELODIPINE; GABAPENTIN; ISRADIPINE;

ALCOHOL CONSUMPTION; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; HIPPOCAMPUS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACETIC ACIDS; ALCOHOLISM; AMINES; ANIMALS; BEHAVIOR, ANIMAL; CALCIUM CHANNEL BLOCKERS; CYCLOHEXANECARBOXYLIC ACIDS; DILTIAZEM; ETHANOL; FELODIPINE; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; ISRADIPINE; MALE; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0031984562     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701596     Document Type: Article

References (32)

1. DOLIN, S.J., HUDSPITH, M.J., PAGONIS, C., LITTLE, H.J. & LITTLETON, J.M. (1987). Increased dihydropyridine-sensitive calcium channels in rat brain may underlie ethanol physical dependence. Neuropharmacology, 26, 275-279.
2. DOLIN, S.J., HUNTER, A.B., HALSEY, M.J. & LITTLE, H.J. (1988). Anticonvulsant profile of the dihydropyridine calcium channel antagonists, nitrendipine and nimodipine. Eur. J. Pharmacol., 152, 19-27.
3. FILE, S.E., BALDWIN, H.A. & HITCHCOTT, P.K. (1989). Flumazenil, but not nitrendipine, reverses the increased anxiety during ethanol withdrawal. Psychopharmacology, 98, 262-264.
4. GEE, M.S., BROWN, J.P., OFFORD, J., THURLOW, R. & WOODRUFF, G.N. (1996). The novel anticonvulsant drug gabapentin (Neurotinin®) binds to the alpha-(2)-delta subunit of a calcium channel. J. Biol. Chem., 271, 5768-5776.
5. GOLDSTEIN, D.B. & PAL, N. (1971). Alcohol dependence produced in mice by inhalation of ethanol: Grading the withdrawal reaction. Science, 172, 288-290.
6. HILL, D., SUMAN-CHAUHAN, N. & WOODRUFF, G.N. (1993). Localisation of [3H]-gabapentin to a novel site in rat brain: autoradiographic studies. Eur. J. Pharmacol. Mol. Pharmacol., 244, 303-309.
7. HUGHES, J., BODEN, P., COSTALL, B., DOMENEY, A.M., KELLY, E.M., HORWELL, D., HUNTER, J.C., PINNOCK, R.D. & WOODRUFF, G.N. (1990). Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc. Natl. Acad. Sci. U.S.A., 87, 6728-6732.
8. LITTLE, H.J., DOLIN, S.J. & HALSEY, M.J. (1986). Calcium channel antagonists decrease the ethanol withdrawal syndrome. Life Sci., 39, 2059-2065.
9. LITTLETON, J.M., LITTLE, H.J. & WHITTINGTON, M.A. (1990). Effects of dihydropyridine calcium channel antagonists in ethanol withdrawal: doses required, stereospecificity and actions of Bay K 8644. Psychopharmacology, 100, 387-392.
10. B transmission, during withdrawal from chronic ethanol treatment, conductance. J. Pharmacol. Exp. Ther., 274, 1035-1041.
11. MOLLEMAN, A. & LITTLE, H.J. (1997). Increased hippocampal calcium currents during withdrawal from chronic ethanol treatment. Br. J. Pharmacol., 120, P371.
12. MORTON, B., RIPLEY, T., WHITTINGTON, M.A. & LITTLE, H.J. (1992). Evidence that changes in hippocampal slice excitability are caused by chronic ethanol administration in vivo. Alcohol Alcoholism, 27, 71-79.
13. PATEL, S., CHAPMAN, K.L., HEALD, A., SMITH, A.J. & FREEDMAN, S.B. (1994). Measurement of central-nervous-system activity of systemically administered CCKB receptor antagonists by ex-vivo binding. Eur. J. Pharmacol., 253, 237-244.
14. RIPLEY, T.L. & LITTLE, H.J. (1995). Ethanol withdrawal hyperexcitability in isolated hippocampal slices is prevented by the competitive NMDA antagonist, CGP39551. Brain Res., 699, 1-11.
15. ROCK, D.M., KELLY, K.M. & MCDONALD, R.L. (1993). Gabapentin actions on ligand- and voltage-gated responses in cultured rat neurones. Epilepsy Res., 16, 89-98.
16. SKEEN, G.A., TWYMAN, R.E. & WHITE, H.S. (1993). The dihydropyridine, nitrendipine, modulates N-methyl-D-aspartate receptor channel function in mammalian neurones. Mol. Pharmacol., 44, 443-450.
17. 3H]-gabapentin binding to a novel site in rat brain: homogenate binding studies. Eur. J. Pharmacol., 244, 293-301.
18. WAMIL, A.W. & MCLEAN, M.J. (1994). Limitation by high frequency action potential firing by mouse central neurones in cell culture. Epilepsy Res., 17, 1-11.
19. WATSON, W.P. & LITTLE, H.J. (1994). Effects of diltiazem in convulsive states differ from those seen with dihydropyridine calcium channel antagonists. Psychopharmacology, 114, 3221-3228.
20. WATSON, W.P. & LITTLE, H.J. (1997a). Effects of GABApentin on ethanol withdrawal signs in mice. Neuropharmacology (in press).
21. WATSON, W.P. & LITTLE, H.J. (1997b). Effects of dihydropyridines on the components of the ethanol withdrawal syndrome; possible evidence for involvement of potassium, as well as calcium? Alcohol Clin. Exp. Res., 21, 409-416.
22. WATSON, W.P., CROSS, A., MISRA, A., LITTLE, H.J. & GREEN, A.R. (1994). Felodipine shows separation between displacement of dihydropyridine binding and prevention of the ethanol withdrawal syndrome. Br. J. Pharmacol., 112, 1017-1024.
23. WATSON, W.P., ROBINSON, E. & LITTLE, H.J. (1995). Gabapentin reduced signs of anxiety-related behaviour measured on the elevated plus-maze during withdrawal from chronic ethanol treatment. Br. J. Pharmacol., 116, 33P
24. WELTY, D.F., SCHIELKE, G.P., VARTANIAN, M.G. & TAYLOR, C.P. (1993). Gabapentin anticonvulsant in rats - disequilibrium with peak drug concentrations in plasma and brain microdialysate. Epilepsy Res., 16, 175-181.
25. WHITTINGTON, M.A. & LITTLE, H.J. (1990). Patterns of changes in field potentials in the isolated hippocampal slice on withdrawal from chronic ethanol treatment of mice in vivo. Brain Res., 523, 237-244.
26. WHITTINGTON, M.A. & LITTLE, H.J. (1991a). Nitrendipine, given during drinking, decreases the electrophysiological changes in the isolated hippocampal slice, seen during ethanol withdrawal. Br. J. Pharmacol., 103, 1677-1684.
27. WHITTINGTON, M.A. & LITTLE, H.J. (1991b). A calcium channel antagonist stereoselectively decreases hyperexcitability induced by ethanol withdrawal, but not that due to bicuculline, in isolated hippocampal slices. Br. J. Pharmacol., 103, 1313-1320.
28. WHITTINGTON, M.A. & LITTLE, H.J. (1993). Changes in voltage-operated calcium channels modify ethanol withdrawal hyperexcitability in mouse hippocampal slices. Exp. Physiol., 78, 347-370.
29. WHITTINGTON, M.A., LITTLE, H.J. & LAMBERT, J.D.C. (1992). Changes in intrinsic inhibition in isolated hippocampal slices during ethanol withdrawal; lack of correlation with withdrawal hyperexcitability. Br. J. Pharmacol., 107, 521-527.
30. WHITTINGTON, M.A., LAMBERT, J.D.C. & LITTLE, H.J. (1995). Increased NMDA-receptor and calcium channel activity during ethanol withdrawal hyperexcitability. Alcohol Alcoholism, 30, 105-114.
31. B antagonists protect against some aspects of the ethanol withdrawal syndrome. Pharmacol. Biochem. Behav. (in press).
32. B antagonists protect against anxiety-related behaviour produced by ethanol withdrawal, measured using the elevated plus-maze. Psychopharmacology (in press).